Evidence map›Paper›PMID 26574513›Full record

ArticleJournal of bacteriology2016

Cyclic Di-GMP Regulates Multiple Cellular Functions in the Symbiotic Alphaproteobacterium Sinorhizobium meliloti.

Simon Schäper, Elizaveta Krol, Dorota Skotnicka, Volkhard Kaever, Rolf Hilker, Lotte Søgaard-Andersen, Anke Becker

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
7.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. International journal of molecular sciences · 2023
    Article
  12. Article
  13. Review
  14. TheMicrobiology (Reading, England) · 2023
    Article
  15. Article
  16. Elongation factor P modulatesProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Simon SchäperLOEWE Center for Synthetic Microbiology (SYNMIKRO), Philipps Universität Marburg, Marburg, Germany.
Elizaveta KrolLOEWE Center for Synthetic Microbiology (SYNMIKRO), Philipps Universität Marburg, Marburg, Germany.
Dorota SkotnickaDepartment of Ecophysiology, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany.
Volkhard KaeverResearch Core Unit Metabolomics, Hannover Medical School, Hannover, Germany.
Rolf HilkerInstitute of Medical Microbiology, Justus Liebig University, Giessen, Germany.
Lotte Søgaard-AndersenDepartment of Ecophysiology, Max Planck Institute for Terrestrial Microbiology, Marburg, Germany.
Anke BeckerLOEWE Center for Synthetic Microbiology (SYNMIKRO), Philipps Universität Marburg, Marburg, Germany anke.becker@synmikro.uni-marburg.de.
Loewe Center for Synthetic Microbiology · DEMax Planck Institute for Terrestrial Microbiology · DEMedizinische Hochschule Hannover · DEPhilipps University of Marburg · DEUniversity of Giessen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledSinorhizobium meliloti undergoes major lifestyle changes between planktonic states, biofilm formation, and symbiosis with leguminous plant hosts. In many bacteria, the second messenger 3',5'-cyclic di-GMP (c-di-GMP, or cdG) promotes a sessile lifestyle by regulating a plethora of processes involved in biofilm formation, including motility and biosynthesis of exopolysaccharides (EPS). Here, we systematically investigated the role of cdG in S. meliloti Rm2011 encoding 22 proteins putatively associated with cdG synthesis, degradation, or binding. Single mutations in 21 of these genes did not cause evident changes in biofilm formation, motility, or EPS biosynthesis. In contrast, manipulation of cdG levels by overproducing endogenous or heterologous diguanylate cyclases (DGCs) or phosphodiesterases (PDEs) affected these processes and accumulation of N-Acyl-homoserine lactones in the culture supernatant. Specifically, individual overexpression of the S. meliloti genes pleD, SMb20523, SMb20447, SMc01464, and SMc03178 encoding putative DGCs and of SMb21517 encoding a single-domain PDE protein had an impact and resulted in increased levels of cdG. Compared to the wild type, an S. meliloti strain that did not produce detectable levels of cdG (cdG(0)) was more sensitive to acid stress. However, it was symbiotically potent, unaffected in motility, and only slightly reduced in biofilm formation. The SMc01790-SMc01796 locus, homologous to the Agrobacterium tumefaciens uppABCDEF cluster governing biosynthesis of a unipolarly localized polysaccharide, was found to be required for cdG-stimulated biofilm formation, while the single-domain PilZ protein McrA was identified as a cdG receptor protein involved in regulation of motility. IMPORTANCE: We present the first systematic genome-wide investigation of the role of 3',5'-cyclic di-GMP (c-di-GMP, or cdG) in regulation of motility, biosynthesis of exopolysaccharides, biofilm formation, quorum sensing, and symbiosis in a symbiotic alpha-rhizobial species. Phenotypes of an S. meliloti strain unable to produce cdG (cdG(0)) demonstrated that this second messenger is not essential for root nodule symbiosis but may contribute to acid tolerance. Our data further suggest that enhanced levels of cdG promote sessility of S. meliloti and uncovered a single-domain PilZ protein as regulator of motility.

Indexed as

Bacterial ProteinsBiofilmsCyclic GMPGene Expression Regulation, BacterialMutationPolysaccharides, BacterialSinorhizobium melilotiBacterial Proteinsbis(3',5')-cyclic diguanylic acidCyclic GMPPolysaccharides, Bacterial

Identifiers

PMID26574513
PMCPMC4719442
OpenAlexW2217310706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.